Background and Aims
Methods
Results
Conclusions
Abbreviations:
CDC (Centers for Disease Control and Prevention), FDA (U.S. Food and Drug Administration), HAC (hyperproduction of AmpC), HLD (high-level disinfection), MDRO (multidrug-resistant organisms)Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gastrointestinal EndoscopyReferences
- Metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type.Clin Microbiol Infect. 2012; 18: E369-E372
- New Delhi metallo-beta-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes.JAMA. 2014; 312: 1447-1455
- Withdrawal of a novel-design duodenoscope ends outbreak of a VIM-2-producing Pseudomonas aeruginosa.Endoscopy. 2015; 47: 493-502
- Endoscopic retrograde cholangiopancreatography-associated AmpC Escherichia coli outbreak.Infect Control Hosp Epidemiol. 2015; 36: 634-642
U.S. Food and Drug Administration. Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning: FDA safety communication. Issued February 19th, 2015. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm434871.htm. Accessed November 6, 2017.
U.S. Food and Drug Administration. Materials of the Gastroenterology-Urology Devices Panel. May 14-15, 2015. Available at: https://wayback.archive-it.org/7993/20170112002249/http:/www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/Gastroenterology-UrologyDevicesPanel/ucm445590.htm. Accessed November 6, 2017.
U.S. Food and Drug Administration. Supplemental measures to enhance duodenoscope reprocessing: FDA Safety Communication. August 4, 2015. Available at: http://wayback.archive-it.org/7993/20170722150658/https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm454766.htm. Accessed November 6, 2017.
Olympus Corporation. Urgent safety notification important updated labeling information: new reprocessing instructions for the Olympus TJF-Q180V duodenoscope. March 26, 2015. Available at: http://medical.olympusamerica.com/sites/default/files/pdf/150326_TJF-Q180V_Customer_letter.pdf. Accessed November 6, 2017.
Olympus Corporation. Urgent medical device removal and corrective action: elevator mechanism replacement, updated operation manual, and new reprocessing instructions for the Olympus TJF-Q180V duodenoscope. January 15, 2016. Available at: http://medical.olympusamerica.com/sites/us/files/pdf/160118-Olympus-TJF-Q180V-Customer-Letter.pdf. Accessed November 6, 2017.
Olympus Corporation. Urgent safety notification important updated labeling information: new reprocessing instructions for the Olympus TJF-160F/VF duodenoscope. March 14, 2016. Available at: http://medical.olympusamerica.com/sites/us/files/pdf/Urgent-Safety-Notification-TJF-Q160F-VF-Duodenoscope.pdf. Accessed November 6, 2017.
- A quarantine process for the resolution of duodenoscope-associated transmission of multidrug-resistant Escherichia coli.Gastrointest Endosc. 2015; 82: 477-483
- Interim protocol for healthcare facilities regarding surveillance for bacterial contamination of duodenoscopes after reprocessing.March 2015 (Available at: https://www.cdc.gov/hai/organisms/cre/cre-duodenoscope-surveillance-protocol.html. Accessed November 6, 2017)
- Getting to zero: reducing the risk for duodenoscope-related infections.Ann Intern Med. 2015; 163: 873-874
- Cost utility of competing strategies to prevent endoscopic transmission of carbapenem-resistant enterobacteriaceae.Am J Gastroenterol. 2015; 110: 1666-1674
Article info
Publication history
Footnotes
DISCLOSURE: All authors disclosed no financial relationships relevant to this publication.
If you would like to chat with an author of this article, you may contact Dr Ross at [email protected]
Identification
Copyright
ScienceDirect
Access this article on ScienceDirectLinked Article
- Reprint of: Comments on duodenoscope reprocessing studyGastrointestinal EndoscopyVol. 89Issue 4
- PreviewAs experts retained by the duodenoscope manufacturer in litigation involving both the manufacturer and the medical center, we obtained access to the study data produced in the litigation. Although we applaud the authors’ communication of important information regarding the challenges of duodenoscope reprocessing, and their successful efforts to control contamination in their facility (including the implementation of a culture and quarantine protocol), we believe that the authors neglected to consider possible trends over time.
- Full-Text
- Preview
- Comments on duodenoscope reprocessing studyGastrointestinal EndoscopyVol. 89Issue 2
- PreviewAs experts retained by the duodenoscope manufacturer in litigation involving both the manufacturer and the medical center, we obtained access to the study data produced in the litigation. Although we applaud the authors’ communication of important information regarding the challenges of duodenoscope reprocessing, and their successful efforts to control contamination in their facility (including the implementation of a culture and quarantine protocol), we believe that the authors neglected to consider possible trends over time.
- Full-Text
- Preview
- Duodenoscope-related and echoendoscope-related infections: Is “never” possible?Gastrointestinal EndoscopyVol. 88Issue 2
- PreviewIn 1999, the term “never event” was introduced by the National Quality Forum (NQF) to refer to particularly egregious and entirely preventable errors such as wrong-site surgery.1 The NQF more recently transitioned toward using the slightly more flexible term “serious reportable events” to describe events that are “unambiguous, usually preventable, serious,” “indicative of a problem in a health care facility's safety systems,” and/or “important for public credibility or…accountability.”2 The widely reported duodenoscope-related outbreaks in the past several years, which have been associated with equipment from all 3 major endoscope manufacturers, meet the NQF criteria for “serious reportable events.”
- Full-Text
- Preview
